Health ❯Healthcare ❯Pharmaceuticals

Cancer Treatment

Immunotherapy Breast Cancer Oncology Small Cell Lung Cancer Clinical Trials Colorectal Cancer Targeted Therapy Prostate Cancer Oncology Research Basal Cell Carcinoma Opdivo Gastrointestinal Cancer mRNA Technology mRNA Therapies mRNA Therapy Multiple Myeloma Radiation Therapy Springworks Therapeutics Menin Inhibitors Amtagvi Lung Cancer Bladder Cancer

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

The potential acquisition aims to bolster Merck's oncology portfolio as it navigates R&D challenges and clinical trial setbacks.

Bristol Myers Squibb Raises 2025 Forecast After Surpassing Q1 Expectations

UK Grants First Global Approval for GSK’s Blenrep in Two Combination Therapies

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development

Biontech's Revenue Surges with Updated Covid-19 Vaccine

FDA Expands Approval of Kisqali for Early-Stage Breast Cancer

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Bristol Myers Squibb Surges on Strong Q2 Performance and Raised Guidance